Streetbeat News

Regulatory

CRLBF

GRWG

MAPS

OGI

VRNOF

The Benzinga Cannabis Capital Conference will take place in Chicago on October 8-9, 2024, gathering key cannabis industry leaders and investors. The event will feature expert panels, networking opportunities, and discussions on cannabis legalization and market opportunities. Notable speakers include leaders from Verano Holdings, Cresco Labs, Organigram, and more.

Portfolio Pulse from Javier Hasse

August 26, 2024 | 4:23 pm

NARI

The FDA has classified the recall of Inari Medical's ClotTriever XL catheter as 'most serious' due to risks of serious adverse health consequences, including death. The recall involves updating usage instructions but not removing the product from the market.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 4:17 pm

TONUSD

USDTUSD

French President Emmanuel Macron has denied political motivations behind the arrest of Telegram founder Pavel Durov, emphasizing it was part of a judicial investigation. The arrest has sparked debates on digital rights and implications for tech companies in Europe. Industry leaders express concerns over freedom of expression and the need for encryption.

Portfolio Pulse from Murtuza Merchant

August 26, 2024 | 4:03 pm

Vice President Kamala Harris proposed measures against price gouging by grocery chains, which could impact companies like Kroger. Concerns arise over potential price controls, which historically led to shortages in other countries. Kroger operates on thin profit margins, and investors are advised to consider hedging against political risks.

Portfolio Pulse from David Pinsen

August 26, 2024 | 4:00 pm

GOOGL

Google is set to update its Gambling & Games policy in Germany, effective September 25. This policy change may impact how gambling-related content is advertised on Google's platforms in Germany.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 3:57 pm

DNA

Ginkgo Bioworks faced a significant downfall after a report by Scorpion Capital accused it of being overpriced and engaging in misleading business practices. The company's stock plummeted, and it faced legal challenges, including a DOJ investigation and a shareholder lawsuit. Ginkgo has agreed to a $17.75 million settlement to resolve the lawsuit. Despite these challenges, the company remains focused on synthetic biology and aims for future growth.

Portfolio Pulse from Stan Vick

August 26, 2024 | 3:51 pm

NVDA

Bitcoin fell below $64,000 amid a shift in focus to AI tokens, with Nvidia's upcoming earnings report influencing market sentiment. Anthony Scaramucci views Bitcoin as an early-adopting technology facing regulatory challenges but sees potential for broader acceptance.

Portfolio Pulse from Murtuza Merchant

August 26, 2024 | 3:43 pm

ABT

DXCM

Dexcom's Stelo Glucose Biosensor System, an FDA-approved over-the-counter continuous glucose monitor, is now available for purchase. It targets Type 2 diabetes patients not using insulin, offering personalized glucose insights without fingersticks. Dexcom collaborates with Amazon for deliveries, and users can pay using flexible spending accounts.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 3:39 pm

BNTX

MRNA

PFE

The US government is restarting its free at-home COVID-19 test program, allowing households to order up to four tests. This comes as the government encourages updated COVID-19 boosters amid rising cases. Moderna, Pfizer, and BioNTech have received EUA for updated vaccines targeting the Omicron variant.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 3:24 pm

EWW

SPY

Mexican President asserts that there is no rational reason for a disruption in trade integration with the United States, indicating stability in economic relations between the two countries.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 3:23 pm